Burns Matteson Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Buy
1,163
+323
+38% +$330K 0.44% 28
2026
Q1
$772K Buy
840
+18
+2% +$18.2K 0.28% 52
2025
Q4
$883K Sell
822
-8
-1% -$7.65K 0.31% 46
2025
Q3
$634K Sell
830
-32
-4% -$23.8K 0.25% 59
2025
Q2
$672K Sell
862
-25
-3% -$19.4K 0.32% 50
2025
Q1
$733K Sell
887
-467
-34% -$389K 0.39% 43
2024
Q4
$1.05M Sell
1,354
-156
-10% -$129K 0.59% 36
2024
Q3
$1.34M Buy
1,510
+58
+4% +$52.1K 0.75% 29
2024
Q2
$1.31M Buy
1,452
+22
+2% +$17.6K 0.83% 26
2024
Q1
$1.11M Sell
1,430
-113
-7% -$80.4K 0.72% 29
2023
Q4
$899K Buy
1,543
+63
+4% +$36.8K 0.63% 32
2023
Q3
$795K Buy
1,480
+9
+0.6% +$4.64K 0.51% 38
2023
Q2
$690K Buy
1,471
+37
+3% +$15.5K 0.42% 47
2023
Q1
$492K Buy
1,434
+72
+5% +$24.3K 0.31% 94
2022
Q4
$498K Buy
1,362
+14
+1% +$4.96K 0.33% 93
2022
Q3
$436K Buy
1,348
+306
+29% +$97K 0.32% 45
2022
Q2
$338K Hold
1,042
0.24% 94
2022
Q1
$298K Hold
1,042
0.21% 98
2021
Q4
$288K Hold
1,042
0.2% 106
2021
Q3
$241K Hold
1,042
0.18% 105
2021
Q2
$239K Buy
+1,042
New +$209K 0.19% 115

Other funds holding LLY

Burns Matteson Capital Management's LLY Position: Q2 2026 in Review

Burns Matteson Capital Management increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $330K and bringing the position to 1,163 shares worth $1.39M. The position accounts for 0.44% of the portfolio, ranked #28.

Burns Matteson Capital Management first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 961 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Burns Matteson Capital Management held 1,163 shares of Eli Lilly worth $1.39M as of Q2 2026.
  • Burns Matteson Capital Management bought 323 Eli Lilly shares in Q2 2026, an estimated $330K.
  • Eli Lilly made up 0.44% of Burns Matteson Capital Management's portfolio in Q2 2026, its #28 holding.
  • Burns Matteson Capital Management first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
  • 961 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.